CP-945,598 Treatment B
Sponsors
Pfizer
Conditions
Obesity
Phase 3
A Long-Term Study To Examine The Effects Of CP-945,598 On Weight Loss And Safety
TerminatedNCT00375401
Start: 2006-10-31End: 2009-01-31Updated: 2012-11-07
A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients
TerminatedNCT00391196
Start: 2006-11-30End: 2009-01-31Updated: 2012-11-07
Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and Safety.
TerminatedNCT00396448
Start: 2007-02-28End: 2009-02-28Updated: 2012-11-07